Dr. David T. Curiel, Professor of Radiation Oncology is a co-collaborator on the vector design for a novel inhaled or nasal vaccine that will soon be in Phase 1 clinical trials here in the US.
Curiel co-designer of vector for new Covid-19 vaccine (Links to an external site)
